Literature DB >> 22905304

Elevated maternal serum α-fetoprotein level in a fetus with Beckwith-Wiedemann syndrome in the second trimester of pregnancy.

Paolo Guanciali-Franchi1, Luisa Di Luzio, Irene Iezzi, Claudio Celentano, Barbara Matarrelli, Marco Liberati, Giandomenico Palka.   

Abstract

BACKGROUND: Beckwith-Wiedemann syndrome (BWS) is a rare disorder characterized by macrosomia, macroglossia, visceromegaly, and omphalocele and an increased risk of growing tumors. Prenatal and postnatal high levels of serum alpha-fetoprotein are associated with several diseases and neoplasms including hepatoblastomas and other hepatic tumors. The diagnosis of BWS is usually made in the postnatal period on the basis of physical exam features and hypermethylation of the H19 gene. CASE: A 30-year-old woman gravida 3, para 2, underwent maternal serum screening at 15 weeks' gestation. The screening was negative for Down's syn drome (risk 1/6085), but positive for NTDs. Further ultrasound examination at 20 and 30 weeks' evidenced a fetal overgrowth and a 3-D scan at 33 weeks' gestation presented a protruding tongue, and a fixed opened mouth caused by macroglossia.
CONCLUSIONS: BWS was suspected on the basis of clinical features, and molecular analysis of critical region 11p15.5 revealing the hypermethylation of H19 gene supported the diagnosis.

Entities:  

Keywords:  Beckwith-Wiedemann syndrome; maternal serum screening; prenatal diagnosis

Year:  2012        PMID: 22905304      PMCID: PMC3414244     

Source DB:  PubMed          Journal:  J Prenat Med        ISSN: 1971-3282


  6 in total

1.  Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia.

Authors:  Carol L Clericuzio; Emily Chen; Dawn Elizabeth McNeil; Timothy O'Connor; Elaine H Zackai; Livija Medne; Gail Tomlinson; Michael DeBaun
Journal:  J Pediatr       Date:  2003-08       Impact factor: 4.406

2.  Clinical features and natural history of Beckwith-Wiedemann syndrome: presentation of 74 new cases.

Authors:  M Elliott; R Bayly; T Cole; I K Temple; E R Maher
Journal:  Clin Genet       Date:  1994-08       Impact factor: 4.438

3.  Serum alpha-fetoprotein levels in Beckwith-Wiedemann syndrome.

Authors:  D B Everman; C Shuman; B Dzolganovski; M A O'riordan; R Weksberg; N H Robin
Journal:  J Pediatr       Date:  2000-07       Impact factor: 4.406

4.  Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry.

Authors:  M R DeBaun; M A Tucker
Journal:  J Pediatr       Date:  1998-03       Impact factor: 4.406

5.  Beckwith-Wiedemann syndrome presenting with an elevated triple screen in the second trimester of pregnancy.

Authors:  Kjersti M Aagaard-Tillery; Alan Buchbinder; Mathew P Boente; Kirk D Ramin
Journal:  Fetal Diagn Ther       Date:  2006-09-21       Impact factor: 2.587

6.  Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.

Authors:  Salvatore Anfuso; Emanuele Soncini; Patrizia Bonelli; Giovanni Piantelli; Dandolo Gramellini
Journal:  Acta Biomed       Date:  2007-12
  6 in total
  3 in total

Review 1.  Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement.

Authors:  Frédéric Brioude; Jennifer M Kalish; Alessandro Mussa; Alison C Foster; Jet Bliek; Giovanni Battista Ferrero; Susanne E Boonen; Trevor Cole; Robert Baker; Monica Bertoletti; Guido Cocchi; Carole Coze; Maurizio De Pellegrin; Khalid Hussain; Abdulla Ibrahim; Mark D Kilby; Malgorzata Krajewska-Walasek; Christian P Kratz; Edmund J Ladusans; Pablo Lapunzina; Yves Le Bouc; Saskia M Maas; Fiona Macdonald; Katrin Õunap; Licia Peruzzi; Sylvie Rossignol; Silvia Russo; Caroleen Shipster; Agata Skórka; Katrina Tatton-Brown; Jair Tenorio; Chiara Tortora; Karen Grønskov; Irène Netchine; Raoul C Hennekam; Dirk Prawitt; Zeynep Tümer; Thomas Eggermann; Deborah J G Mackay; Andrea Riccio; Eamonn R Maher
Journal:  Nat Rev Endocrinol       Date:  2018-01-29       Impact factor: 43.330

Review 2.  Diagnosis and Management of Beckwith-Wiedemann Syndrome.

Authors:  Kathleen H Wang; Jonida Kupa; Kelly A Duffy; Jennifer M Kalish
Journal:  Front Pediatr       Date:  2020-01-21       Impact factor: 3.418

3.  Proposal for Practical Approach in Prenatal Diagnosis of Beckwith-Wiedemann Syndrome and Review of the Literature.

Authors:  Gwo-Chin Ma; Tze-Ho Chen; Wan-Ju Wu; Dong-Jay Lee; Wen-Hsiang Lin; Ming Chen
Journal:  Diagnostics (Basel)       Date:  2022-07-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.